Schizophrenia and the Family Burden During the Pandemic

Marin, Ioana-Maria; Petropolou, Maria; Baroiu, Liliana; Chirosca, Ana-Catalina; Anghel, Lucreția; Luca, Laurențiu

doi:10.18662/brain/11.3sup1/125

Cited by 6 publications

(9 citation statements)

References 8 publications

(8 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Their knowledge about schizophrenia will lead them to understand the patient's drama and behavior. Education also includes effective communication, problem-solving, and coping skills to find the family's internal strength despite stigmatization and to help them develop social support and social integration [18].…”

Section: Discussionmentioning

confidence: 99%

Training for Mental Health Volunteers of People Living with Schizophrenia in the COVID-19 Pandemic in Bangkalan City

Julia Dian Christiani Adi Santoso,

Joewen Sarliency Manafe,

Dayu Triana Rahmawati

et al. 2023

JPS

View full text Add to dashboard Cite

Introductions: The global coronavirus-19 (COVID-19) pandemic disproportionately burdens people with schizophrenia and related disorders. Access to mental health providers in rural areas was still far from expected. People with schizophrenia in low and middle-income countries, including Bangkalan City, often lack access to evidence-based treatments. We hypothesized that psychoeducation might improve Mental Health Volunteers’ (MHV) knowledge and skills to help people with schizophrenia in rural areas. Furthermore, we want to identify the obstacles and practical solutions essential to improving the community’s mental health in Bangkalan City. Methods: The total participants were 134 MHV from the Department of Health, Bangkalan City. The data was collected in pretest and posttest on each workshop session and Focus Group Discussion (FGD). Results: There were significant improvements in the knowledge and skills about Schizophrenia of MHVs and programmers from the Department of Health, Bangkalan City (p<0.01). The three most common problems raised in FGD were communication with people with schizophrenia and their families due to health protocols, appeals from community leaders contrary to health policies, and family conflicts. Conclusions: Training for MHV in the Department of Health, Bangkalan City, has improved their understanding of schizophrenia and its interventions, their communication skills with people with schizophrenia and their families, and their skills to handle psychiatric emergencies related to schizophrenia. The three most common problems and the solutions were agreed upon during FGD.

show abstract

Section: Discussionmentioning

confidence: 99%

Training for Mental Health Volunteers of People Living with Schizophrenia in the COVID-19 Pandemic in Bangkalan City

Julia Dian Christiani Adi Santoso,

Joewen Sarliency Manafe,

Dayu Triana Rahmawati

et al. 2023

JPS

View full text Add to dashboard Cite

show abstract

“…Elderly patients with multiple comorbidities have an increased risk of infection in general and COVID-19 in particular. 38 , 39 Demonstration of severe prognosis in this patient profile, elderly with multiple comorbidities requires the establishment of a set of personalized prophylactic measures, such as priority vaccination, hygiene measures and increased isolation, easy and quick access to specific antiviral therapy, mandatory measures to improve the prognosis of these patients. 40 …”

Section: Discussionmentioning

confidence: 99%

The Role of D-Dimers in the Initial Evaluation of COVID-19

Baroiu¹,

Lese²,

Ștefanopol³

et al. 2022

TCRM

Self Cite

View full text Add to dashboard Cite

Purpose The COVID-19 pandemic was noted for the high degree of contagion and the large number of cases, as well as for the various clinical forms, from asymptomatic towards rapid evolution to death. The hospitals limited care capacity imposed the need to identify some markers of unfavorable evolution. The purpose of our study is to identify the parameters correlated with COVID-19 unfavorable evolution and to draw the profile of the patient at risk of unfavorable evolution. This set of parameters will help the doctor in deciding whether to hospitalize a patient and in choosing the treatment. Patients and Methods We performed a prospective, observational, actively controlled study on 849 patients with COVID-19, hospitalized in the Second Clinic of “Sf. Cuv. Parascheva” Infectious Diseases Clinical Hospital Galati, Romania, between 1.03.2020–30.11.2020. Results The parameters statistically significant modified at the admission of the patients with COVID-19 unfavorable evolution were age, oxygen saturation, D-dimers, creatine kinase (CK), troponin, erythrocytes sedimentation rate (ESR), leukocytes, lymphocytes, neutrophils, platelets, hemoglobin (Hb), aspartate transaminase (AST), total and direct bilirubin (TBIL, DBIL), urea, creatinine, serum glucose. Strong correlations were observed between the unfavorable evolution and the admission values of D-dimers, AST, TBIL and between D-dimers and AST, which suggests that D-dimers levels can be considered predictive for the alteration of liver function and for the negative prognosis of the patient. Conclusion Coagulation disorders and acute respiratory failure are the prevailing causes of death from COVID-19. Together with other parameters that constitute the risk profile for severe COVID-19 evolution, the D-dimers dosing at admission proved to be extremely useful in the management of COVID-19.

show abstract

“…When dealing with insomnia there is a need to assess a plethora of factors that can cause it, such as chronic medical conditions (Parkinson's disease, dementia, schizophrenia, depression, chronic obstructive pulmonary disease, congestive heart failure and pain) and concomitant medication ( 29 ). Several medicines favor or cause insomnia, such as selective serotonin reuptake inhibitors, dopamine agonists, antipsychotics, theophylline, anticonvulsants, decongestants, β-agonists, antihypertensive drugs (α-agonists andβ-blockers), diuretics, thyroid hormone, steroids, caffeine, alcohol and niacin ( 29 , 30 ). Melatonin and melatonin agonists are considered safer than benzodiazepines and nonbenzodiazepines ( 31 , 32 ).…”

Section: Melatonin and Insomniamentioning

confidence: 99%